Table 5.
Hematogenous stage and cure.
| Stage | Overall cured (%) | Cured “a” Patients without debridement (%) |
Cured “b” Patients with>l debridement (%) |
|---|---|---|---|
| 1 | 6/9 (66.7) | 1/4(25) | 5/5(100) |
| 2 | 34/36 (94.7) | 17/18 (94.4) | 17/18 (94.4) |
| 3 | 4/4(100) | 1/1(100) | 3/3(100) |
| 4 | 37/46 (80.4) | 15/16 (93.8) | 22/30 (73.3) |
| 5 | 7/12 (58.3) | 2/3 (66.7) | 5/9 (55.6) |
| Total | 88/107 (82.6) | 36/42 (85.7) | 52/65(80) |
| 1-3 (confined to bone) | 46/51 (90.2) | 20/24 (83.3) | 17/19 (89.5) |
| 4-5 (extension to soft tissue) | 44/58 (75.9) | 17/19 (89.5) | 27/39 (69.2)* |
*P<0.02